Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease
Tiago Sousa1, Paula I Moreira2,3,4, Susana Cardoso2,3,5
1Faculty of Medicine, University of Coimbra, 3000-370 Coimbra, Portugal.
Alzheimer's disease (AD) treatments are lacking. This review highlights mitochondrial dysfunction in AD and explores therapeutic strategies targeting mitochondria for early intervention.
Area of Science:
- Neurodegenerative Disorders
- Cellular Biology
- Mitochondrial Medicine
Background:
- Alzheimer's disease (AD) is a leading cause of neurodegeneration, impacting patients and caregivers.
- Current treatments for AD are ineffective, partly due to late-stage diagnosis.
- Early detection and intervention are crucial for developing effective AD therapies.
Purpose of the Study:
- To review evidence of mitochondrial dysfunction in Alzheimer's disease.
- To explore novel therapeutic strategies targeting mitochondria in AD.
Main Methods:
- Literature review of previous and recent studies on mitochondrial dysfunction in AD.
- Analysis of therapeutic strategies targeting mitochondria.
Main Results:
- Mitochondria in AD patients and models exhibit dysfunction compared to non-AD individuals.
- Mitochondrial health and function are promising targets for AD treatment.
Conclusions:
- Targeting mitochondrial dysfunction represents a key strategy for developing early interventions for Alzheimer's disease.
- Further research into mitochondria-focused therapies could lead to effective treatments for AD.
More Related Videos
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
11:47Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria